Anzeige
Mehr »
Montag, 17.11.2025 - Börsentäglich über 12.000 News
Die KI-Comeback-Story des Jahres 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12FCC | ISIN: US47973J1025 | Ticker-Symbol:
NASDAQ
14.11.25 | 21:59
8,230 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
JOINT CORP Chart 1 Jahr
5-Tage-Chart
JOINT CORP 5-Tage-Chart

Aktuelle News zur JOINT CORP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.11.The Joint Corp. outlines system-wide sales guidance of $530M-$534M while expanding national marketing strategy2
05.11.The Joint Corp. expands stock buyback by $12M; shares up1
05.11.The Joint Corp. stockt Aktienrückkaufprogramm um 12 Millionen US-Dollar auf1
05.11.The Joint Corp. adds $12 million to stock repurchase program1
05.11.The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program2
06.10.JOINT Corp - 8-K, Current Report-
JOINT CORP Aktie jetzt für 0€ handeln
03.10.The Joint Chiropractic expands into Delaware with first clinic3
30.09.The Joint appoints Debbie L. Gonzalez as CMO4
30.09.The Joint Corp. appoints Debbie Gonzalez as new chief marketing officer1
30.09.The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer360SCOTTSDALE, Ariz., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced Debbie L....
► Artikel lesen
26.09.JOINT Corp - S-8, Securities to be offered to employees in employee benefit plans1
27.08.JOINT Corp - 8-K, Current Report1
08.08.The Joint Corp Q2 2025 slides: Refranchising accelerates as EBITDA jumps 52%1
31.07.The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges136- Expects to reduce 2024 net loss and increase carrying value of assets held for sale by approximately $2.2 million - - Expects to increase first quarter 2025 net income by approximately $0.5 million...
► Artikel lesen
30.07.JOINT Corp - 8-K, Current Report2
07.07.JOINT Corp - 8-K, Current Report1
07.07.The Joint stock price target lowered to $16 at Lake Street Capital1
07.07.The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region316- Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics - - Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in Royalties and Franchise...
► Artikel lesen
27.06.JOINT Corp - 8-K, Current Report1
25.06.The Joint sells 36 clinics in strategic refranchising, expansion deals; shares up1
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1